Asada H, Shibata K, Uchida K, Takeyama Y, Saitoh Y, Ohyanagi H
Shionogi Diagnostics Research Laboratories, Shionogi & Co. Ltd., Osaka, Japan.
Clin Chim Acta. 1993 Sep 17;218(1):17-27. doi: 10.1016/0009-8981(93)90218-s.
We have recently reported the occurrence of anti-elastase 1 autoantibodies in human sera (Asada et al., Biochim Biophys Acta, 1991;1080:34-39). The usual radioimmunoassay of elastase 1 in autoantibody-positive sera gave abnormally high levels of elastase 1 and low recoveries of elastase 1 added to the sera. Now we have established a new radioimmunoassay system for determining pancreatic elastase 1 in serum, in which alpha 1-antitrypsin elastase 1 conjugate, the major conjugation form of elastase 1 in serum, is used as standard and alpha 1-antitrypsin-[125I]elastase 1 as tracer, because we found that the conjugate could bind to the elastase 1 specific antiserum but not to the autoantibodies. Thus the new assay system completely eliminate the unfavorable effects of the autoantibodies. The elastase 1 levels determined by the new assay method exhibited a good correlation with those obtained by a commercial assay kit in the autoantibody-negative sera, while no correlation was observed in the autoantibody-positive sera.
我们最近报道了在人血清中出现抗弹性蛋白酶1自身抗体(浅田等人,《生物化学与生物物理学报》,1991年;1080:34 - 39)。在自身抗体阳性血清中常规的弹性蛋白酶1放射免疫测定法显示弹性蛋白酶1水平异常高,且添加到血清中的弹性蛋白酶1回收率低。现在我们建立了一种用于测定血清中胰腺弹性蛋白酶1的新放射免疫测定系统,其中血清中弹性蛋白酶1的主要结合形式α1 - 抗胰蛋白酶弹性蛋白酶1结合物用作标准品,α1 - 抗胰蛋白酶 - [125I]弹性蛋白酶1用作示踪剂,因为我们发现该结合物能与弹性蛋白酶1特异性抗血清结合,但不与自身抗体结合。因此,新的测定系统完全消除了自身抗体的不利影响。通过新测定方法测定的弹性蛋白酶1水平在自身抗体阴性血清中与通过商业测定试剂盒获得的水平呈现良好的相关性,而在自身抗体阳性血清中未观察到相关性。